NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Corona Mega Merger - Astrazeneca/gilead, OPEC Extend And Apple Record High

Published 08/06/2020, 06:44
USD/JPY
-
UK100
-
XAU/USD
-
DJI
-
DE40
-
MSFT
-
GILD
-
AAPL
-
AZN
-
GC
-
CL
-
IXIC
-
DXY
-
  • CORONA MEGA MERGER - AstraZeneca PLC (LON:AZN) approaches Gilead Sciences (NASDAQ:GILD)
  • Oil higher after OPEC reach agreement to extend output cuts
  • China trade surplus reaches record high
  • Apple shares (NASDAQ:AAPL) reach record high & reclaims title of largest company
  • Inspiration

    “I just wait until there is money lying in the corner, and all I have to do is go over there and pick it up. I do nothing in the meantime.” - Jim Rogers

    Opening Calls

    FTSE 100 to open 27 points lower at 6457

    DAX to open to open 46 points lower at 12,801

    Dow to open 40 points higher at 27,150

    European shares look headed for a softer start. AstraZeneca will be one to watch on the FTSE over plans to buy Remdesivir-maker Gilead Sciences. The DAX is pointed lower as investors await new information on German industrial output in April. Shares in Asia were mostly higher after China reported a record trade surplus. Futures point to a stronger open on Wall Street.

    Markets

    It will be a challenge to maintain the sheer optimism on display from Friday. The blowout jobs report has got economists talking about V-shaped recoveries. All the while the market has been doing its own V. The record high in the Nasdaq index is astonishing but had looked like an growing inevitability since crossing above its 200-day moving average.

    AstraZeneca & Gilead

    AstraZeneca wants to be the GoTo COVID treatment company. That’s according to a weekend report from Bloomberg that said Astra had contacted Gilead Sciences about a merger. AstraZeneca with the vaccine and Gilead with Remdesivir as a treatment. The combination would be valued at over £200 billion.

    It would be the first Corona-mega merger. What better time to have the biggest ever health-care deal than in a global health crisis? With central banks keeping financing costs pressed into the floor but a cloudy economic outlook, M&A as a path to growth will be tempting for many big firms. There are some clear practical constraints on completing such a big deal with travel restrictions in place. That would suggest any deal would be quite some way off, potentially (hopefully) even after the pandemic has passed.

    Dollar down with havens

    The US dollar ended Friday higher but finished its third week lower. Investors are backing off from havens like US Treasuries and the Japanese yen and are no longer scrambling for dollar-liquidity amid the smooth-sailing in markets. Gold prices could be teetering on a bigger decline, having dropped decisively below $1700 per oz.

    OPEC

    Oil prices have edged up after OPEC agreed to extend existing cuts for another month. One month doesn’t really move the needle but shows OPEC+ is still in the game. The critical ingredient for the price of oil is the belief in economic recovery; OPEC just needed to hold steady.

    Chart

    Apple Inc - 240 Min Chart

    As the Nasdaq reached record highs - so did Apple (AAPL) - reclaiming its title of largest company by market capitalisation from Microsoft (NASDAQ:MSFT).

    Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.